Humacyte HUMA
NASDAQ HUMA
$0.66 -0.02 (-2.55%)
As of: Aug 21, 2026 · 1:34 PM EDT

Humacyte (HUMA) EBIT Margin Growth (1y) (2021 - 2026)

Humacyte (HUMA) EBIT Margin Growth (1y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 139.35 Bn 131.50 Bn 2.84 Bn -143.00
2 Regeneron Pharmaceuticals 86.12 Bn 78.12 Bn 3.93 Bn 78.00
3 Argenx Se 65.22 Bn 60.03 Bn 1.37 Bn 1,135.00
4 Moderna 58.98 Bn 53.84 Bn 52.00 Mn 7,666.00
5 BeOne Medicines 42.08 Bn 36.99 Bn 1.53 Bn 1,238.00
6 Alnylam Pharmaceuticals 31.61 Bn 28.30 Bn 992.69 Mn 2,002.00
7 BioNTech SE 27.98 Bn 9.59 Bn 668.28 Mn -3,558.00
8 Insmed 27.46 Bn 26.30 Bn 358.27 Mn 29,091.00
9 Royalty Pharma 27.30 Bn 26.47 Bn - -1,651.00
10 Humacyte 155.52 Mn 155.52 Mn -825,000.00 322,682.00

Historic Data

Download Data
DateValue
Jun 30, 2026 322,682.00
Mar 31, 2026 -135,096.00
Sep 30, 2021 -664,081.00